Health · Medical Research · 4 hrs ago
DUOTAP Trial Finds Benefits From Routine Postdilation in TAVR
The DUOTAP trial examined routine postdilation during transcatheter aortic valve replacement, or TAVR.
TAVR is the procedure named in the study, which used a balloon-expandable platform.
The trial found that routine postdilation largely corrected a problem during the procedure.
The source does not specify what that problem was.
It also says the approach provided several benefits, but does not detail them.
The findings concern how TAVR is carried out, but no next steps are given.
The DUOTAP trial reported benefits from routine postdilation during transcatheter aortic valve replacement.
The findings concern TAVR using a balloon-expandable platform.
The article described the evidence as emerging.
Routine postdilation largely corrected an issue, but the available article text does not specify what was corrected.
- Who
- The DUOTAP trial researchers; their names are not stated.
- What
- The trial found benefits from routine postdilation during TAVR.
- When
- The article was published on November 5, 2026; the trial date is not stated.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Trial
- DUOTAP
- Procedure
- Transcatheter aortic valve replacement (TAVR)
- Valve platform
- Balloon-expandable
- Publication date
- November 5, 2026